Cite
MLA Citation
Hyunji Lim et al.. “2022-RA-1504-ESGO Tamoxifen-megestrol acetate combination hormonal therapy is an effective fertility-sparing treatment in early-stage endometrial cancer patients who have failed progestin only hormonal therapy.” International journal of gynecological cancer, vol. 32, n.d., pp. A154–A155. http://access.bl.uk/ark:/81055/vdc_100168339712.0x000037